Emulate Revenue and Competitors

Claim your profile

Boston, MA USA

Location

#6626

Growjo Ranking

Biotech

Industry

Estimated Revenue & Valuation

  • Emulate's estimated annual revenue is currently $21.7M per year.(i)
  • Emulate received $36.0M in venture funding in June 2018.
  • Emulate's estimated revenue per employee is $155,000
  • Emulate's total funding is $224.3M.

Employee Data

  • Emulate has 140 Employees.(i)
  • Emulate grew their employee count by 27% last year.
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$9.7M45N/AN/AN/A
#2
$13.6M101-28%N/AN/A

We work at the intersection of biology, engineering, and design, developing technologies that emulate human biology. Our products are enabling a new era of precision medicine and the development of applications for personalized health. Our Human Emulation System, which uses Organs-on-Chips technology, is being used by industry, government, and academia to understand how different diseases, medicines, chemicals and foods affect human health. The system offers researchers a new standard for predicting human response - with greater precision and control than today's cell culture or animal-based experimental methods. We are also leading a bold, new precision medicine initiative with our clinical partners. Named "Patient-on-a-Chip," the program is developing personalized chips with patients' own cells. This initiative will help transform the way each of us understands our own bodies and manages our own health. Research conducted using our Organ-Chips has been published in high-impact scientific journals, including Science. In addition, Organ-Chips have been acquired by the Museum of Modern Art (MoMA) in New York for their permanent collection, and have also been awarded Product Design of the Year 2015 by London's Design Museum. Our founding team pioneered the original Organs-on-Chips technology during their residency within the Wyss Institute for Biologically Inspired Engineering at Harvard University.

keywords:Biotechnology,Healthcare,Pharmaceuticals

$224.3M

Total Funding

140

Number of Employees

$21.7M

Revenue (est)

27%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Emulate News

2021-05-18 - Emulate Announces Colon Intestine-Chip Grant Program to Inspire Research into Intestinal Diseases

BOSTON, May 18, 2021 /PRNewswire/ -- Emulate, Inc., a leading provider of advanced in vitro models, today launched the Emulate Colon Intestine-Chip Grant Program. The program will help researchers begin using Organs-on-Chips technology to study intestinal diseases. The Emulate Colon Intestine- ...

2021-09-07 - Emulate Closes $82 Million Series E Financing to Scale Amid Rapid Growth in Organ-on-a-Chip Market

Emulate, Inc., a leading provider of next generation in vitro models, today announced the close of an $82 million Series E financing round led by existing investor Northpond Ventures with additional participation from Perceptive Advisors. With this investment, Emulate has raised nearly $225 mill ...

2021-09-07 - Emulate Raises $82M in Series E Funding

Emulate, Inc., a Boston, MA-based provider of next generation in vitro models, closed an $82m Series E financing round. The round, which brought total funding raised to date to nearly $225m, was led by existing investor Northpond Ventures with participation from Perceptive Advisors. The compan ...

20-Mar-19 - Ryan Giggs Says Juventus Move Will Help Aaron Ramsey Emulate

Wales manager Ryan Giggs has backed Aaron Ramsey to find success at Juventus, saying the Arsenal midfielder can emulate Real Madrid

20-Mar-19 - SNC-Lavalin would be wise to emulate Maple Leaf Foods

Maple Leaf could have blamed sloppy employees for the deadly listeria outbreak. It could have blamed faulty machinery. It could have blamed

17-Mar-19 - Philadelphia 76ers guard Ben Simmons has the ability to emulate Hall

Since being selected with the top pick in the 2016 draft, Simmons has drawn comparisons with five-time NBA champion Johnson, due to his

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$49.7M1401%N/A
#2
$21.1M1408%$18.1M
#3
$35M14063%N/A
#4
$21.7M14084%$368.6M
#5
$31.6M1406%N/A

Emulate Funding

DateAmountRoundLead InvestorsReference
2014-07-29$12.0MANanoDimensionArticle
2016-03-29$28.0MBOS FundArticle
2016-10-21$17.0MBMultipleArticle
2018-06-20$36.0McFounders FundArticle